Viewing Study NCT04273334



Ignite Creation Date: 2024-05-06 @ 2:17 PM
Last Modification Date: 2024-10-26 @ 1:28 PM
Study NCT ID: NCT04273334
Status: UNKNOWN
Last Update Posted: 2020-02-18
First Post: 2020-02-15

Brief Title: Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders
Sponsor: Peking Union Medical College Hospital
Organization: Peking Union Medical College Hospital

Study Overview

Official Title: Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders Including Lymphedema Lymphangioma Lymphangioleiomyomatosis Plastic Bronchitis Lymphadenopathy Caused by Rheumatoid Arthritis Etc
Status: UNKNOWN
Status Verified Date: 2020-02
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is an open-label whole-body PETCT study for investigating the value of 68Ga NEB PET imaging in the diagnosis and evaluation of lymphatic disorders including lymphedema lymphangioma lymphangioleiomyomatosis plastic bronchitis lymphadenopathy caused by rheumatoid arthritis etc
Detailed Description: No fasting hydration or other specific preparation was requested on the day of imaging

Patients for lymphatic drainage disorders imaging underwent whole-body PETCT acquisitions 20-40 min after subcutaneously injected into first and second interdigital spaces of both feet or hands of 74-111 MBq 2-3 mCi 68Ga-NEB with each bed position lasted for 2 min

A MIM workstation was used for post-processing The visual method was used to evaluate the lymphatic system including the morphology and the distribution of the lymphatic system Semiquantitative methods were applied for image analysis

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None